Immune Systems Advisor

A newer COVID-19 variant may be causing a severe sore throat in some people who contract the infection. The variant, known as NB.1.8.1 (Nimbus), has been nicknamed by some as "razor blade throat" due to the painful symptom . Dr. McCullough appeared on Real America’s Voice Just the News with Amanda Head and said that the sore throat means the virus has been in the nasal cavity silently reproducing for at least five days before the onset of the sore throat. Because vaccines don’t work, the only way to help reduce the risk of Nimbus is twice daily nasal sprays and gargles. It must be done routinely and not just in reaction to the onset of symptoms where it is too late. COVID-19 Variant "Nimbus" NB.1.8.1 Causing 'Razor Blade Throat' by Peter A. McCullough, MD, MPH Strong Call for Twice Daily Nasal Spray and Gargle Regimen Read on Substack COVID-19 Variant "Nimbus" NB.1.8.1 Causing 'Razor Blade Throat' Strong Call for Twice Daily Nasal Spr...

Dr. Peter McCullough has impeccable academic credentials. He's an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals. Dilute Povidone Iodine or Betadine (a 1% solution) gargling and as a nasal spray on a regular basis twice a day for prevention and then if you have been exposed or are in early stages use at least 4 or potentially 6 times a day. You can also use dilute hydrogen peroxide or dilute sodium hypo chloride or even Scope or Listerine – obviously do not swallow and spit out. Updates:  Efficacy and Advantages of Nasopharyngeal and Oropharyngeal Treatments for Early Intervention and Prophylaxis in Respiratory Viral Infections : A Systematic Review and Meta-Analysis (2025) How to Detox Sp...

Abstract: Low-cost systemic treatments, including ivermectin, hydroxychloroquine (HCQ), metformin, antiandrogens, antihistamine H1RAs, curcumin, melatonin, colchicine, probiotics, azvudine, N-acetylcysteine (NAC), fluvoxamine, nigella sativa, famotidine, and quercetin, demonstrate significant efficacy against SARS-CoV-2. This systematic review synthesizes evidence from 423 HCQ studies, 105 ivermectin studies, and numerous trials for other treatments, supported by in silico, in vitro, and animal studies. Early treatment and prophylaxis with HCQ show strong efficacy (p<0.0000000001)*, with the largest RCT reporting 57% lower symptomatic PCR+ COVID-19 (p=0.0002). Ivermectin exhibits efficacy across prophylaxis (96% lower high viral load cases), early, and late treatment (p<0.0000000001), with 36% lower long COVID risk (p<0.0001). Polytherapy enhances outcomes (68% [57-77%] risk reduction) compared to monotherapy (33% [30-36%]), driven by synergistic effects. Despite challenges li...